Intelsat S.A. (I) Prices IPO at $18/Share
April 18, 2013
(In April 10 item, corrects size of mandatory convertible bond deal to $150 million from $700 million in 11th paragraph) Read More
category
companyNews
The third week of April is going to be a busy one for our IPO calendar . Six companies will be making their debut including some of the most anticipated offerings of the year so far. The aftermarket... Read More
from Money Morning
DEALTALK-Intelsat to test investors' love for leverage
April 10, 2013
April 10 (Reuters) - Intelsat Global Holdings S.A. plans to test investors' tolerance for financial leverage in a proposed $500 million IPO next week, as the satellite operator tries to take advantage... Read More
category
companyNews
Intellipharmaceutics Announces First Quarter 2013 Results
April 03, 2013
Top Stocks: Cumberland Pharmaceuticals, MEI Pharma Inc, IntelliPharmaCeutics Intl Inc, Simcere Pharmaceutical Group
March 28, 2013
Intellipharmaceutics to Raise US$3.1 Million
March 19, 2013
Stocks Alert: Multiband Corporation, IntelliPharmaCeutics Intl Inc, Emerson Radio Corp, Magnetek
March 14, 2013
Drug Delivery Stocks Recap: pSivida Corp, IntelliPharmaCeutics Intl Inc, Petmed Express Inc, Alkermes Plc
March 11, 2013
Stocks to Watch: Elan Corporation, Flamel Technologies, IntelliPharmaCeutics Intl Inc, Alkermes Plc
February 27, 2013
Intellipharmaceutics Announces 2012 Year End Results
January 31, 2013
Maxim Group Starts IntelliPharmaCeutics International (IPCI) at Buy
January 31, 2013
Let’s think, for a moment, about why people want more money: (1) To buy stuff. (2) To keep score. (3) To accumulate power. Perhaps there are others, but these seem to me to be the big three. OK, so... Read More
from Wall Street Pit
TABLE-BHP Billiton Q2 production of key commodities
January 22, 2013
SYDNEY, Jan 23 (Reuters) - Following is a list of BHP Billliton production figures for key commodities in its second quarter ended December 31. Read More
category
companyNews
In trading on Wednesday, shares of Intellipharmaceutics International Incorporated (I) crossed below their 200 day moving average of $2.90, changing hands as low as $2.72 per share.... Read More
category
Dividends
from Dividend Channel
Intellipharmaceutics Announces Third Quarter 2012 Results
October 02, 2012
I.CA Makes Notable Cross Below Critical Moving Average
September 24, 2012
In trading on Monday, shares of Intellipharmaceutics International Incorporated (I) crossed below their 200 day moving average of $2.91, changing hands as low as $2.78 per share. Intellipharmaceutics... Read More
category
Dividends
from Dividend Channel
Brean Murray Carret & Co. Starts IntelliPharmaCeutics International (IPCI) at Buy
September 11, 2012
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here